Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02020460 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Direct Dorsal Column Stimulation
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02020460 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 6 participants.
The verdict
NCT02020460, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The study will examine the feasibility of Direct Dorsal Column Stimulation using existing Stimulation Leads (Ad-Tech). Secondary endpoints will include pain relief, somatosensory evoked potentials (SSEPs), stimulator settings required, improvement in quality of life and use of pain medications.
Interventions
- DEVICE Subdural trial lead
- DEVICE Epidural trial lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02020460
The ClinicalTrials.gov registry entry for NCT02020460 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Subdural trial lead is the first listed.
NCT02020460 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02020460 about?
NCT02020460 is a clinical study titled "Clinical Evaluation of Direct Dorsal Column Stimulation". The study will examine the feasibility of Direct Dorsal Column Stimulation using existing Stimulation Leads (Ad-Tech). Secondary endpoints will include pain relief, somatosensory evoked potentials (SSEPs), stimulator settings required, improvement in quality of life and use of pain medications.
What is the current status of trial NCT02020460?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2012-06. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02020460?
The interventions under investigation include: Subdural trial lead (DEVICE), Epidural trial lead (DEVICE).
Who is sponsoring clinical trial NCT02020460?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.